GARDASIL 9: 99 Clinical Trials, Page 1 of 10

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

Condition(s):Papillomavirus Vaccines; Human Immunodeficiency Virus; Papillomavirus Infection; Serology; Cervical Intraepithelial Neoplasia; Anal Intraepithelial Neoplasia; Oral Cavity InfectionLast Updated:March 4, 2022Not yet recruiting

Immunogenicity and Safety of Gardasil-9 and Cervarix

Condition(s):HPV Vaccines Immunogenicity and SafetyLast Updated:January 18, 2019Completed

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Condition(s):Human Papillomavirus VaccinesLast Updated:February 13, 2018Completed

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil^®9 in Healthy Females 18-26 Years of Age

Condition(s):Cervical Cancer; Condylomata AcuminataLast Updated:February 11, 2022Active, not recruiting

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Condition(s):Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell NeoplasmLast Updated:June 30, 2022Active, not recruiting

Study of Safety, Tolerability and Immunogenicity of Gardasil^®9 in Immunocompromised Patients

Condition(s):Human Papilloma Virus; Hiv; Organ TransplantsLast Updated:December 11, 2020Completed

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial

Condition(s):NeoplasiaLast Updated:August 29, 2019Not yet recruiting

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Condition(s):Immunization; Efficacy; Human Papilloma VirusLast Updated:April 25, 2022Recruiting

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Condition(s):Papillomavirus Infections; Uterine Cervical Neoplasms; Vulvar Neoplasms; Vaginal Neoplasms; Adenocarcinoma in Situ; Condylomata AcuminataLast Updated:February 25, 2020Completed

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Condition(s):HPV InfectionLast Updated:December 20, 2021Recruiting

1 2 3 4 5 …10 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.